Naveed Sattar
Sattar, Naveed.
VIAF ID: 46201627 (Personal)
Permalink: http://viaf.org/viaf/46201627
Preferred Forms
-
100 0 _
‡a
Naveed Sattar
-
100 1 _ ‡a Sattar, Naveed (sparse)
-
100 1 _
‡a
Sattar, Naveed
-
100 1 _
‡a
Sattar, Naveed
-
100 1 _ ‡a Sattar, Naveed
-
100 1 _ ‡a Sattar, Naveed
-
100 1 _
‡a
Sattar, Naveed
-
100 1 _
‡a
Sattar, Naveed
-
100 1 _ ‡a Sattar, Naveed
-
100 1 _ ‡a Sattar, Naveed
-
100 1 _ ‡a Sattar, Naveed.
4xx's: Alternate Name Forms (2)
5xx's: Related Names (2)
Works
| Title | Sources |
|---|---|
| ABC of obesity, 2007: |
|
| Abc otyłości |
|
| Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium |
|
| Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group |
|
| Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus |
|
| Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial |
|
| Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. |
|
| Effects of Acquired Obesity on Endothelial Function in Monozygotic Twins* |
|
| Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker |
|
| Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes |
|
| Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials |
|
| Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers |
|
| Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study |
|
| Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease |
|
| Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. |
|
| Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials |
|
| Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study |
|
| Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
|
| Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
|
| Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients |
|
| Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC) |
|
| Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort |
|
| Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time |
|
| Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. |
|
| Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke |
|
| Low vitamin D levels are related to left ventricular concentric remodelling in men of different ethnic groups with varying cardiovascular risk |
|
| Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK. |
|
| Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation |
|
| Major lipids, apolipoproteins, and risk of vascular disease |
|
| Management of Lipid Abnormalities in Patients with Diabetes |
|
| Management of obesity: summary of SIGN guideline |
|
| Managing cardiovascular risk in rheumatoid patients |
|
| Markers of endothelial dysfunction and cerebral blood flow in older adults |
|
| Maternal adiposity--a determinant of perinatal and offspring outcomes? |
|
| Maternal docosahexaenoic acid supplementation and fetal accretion |
|
| Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways |
|
| Maternal Plasma DHA Levels Increase Prior to 29 Days Post-LH Surge in Women Undergoing Frozen Embryo Transfer: A Prospective, Observational Study of Human Pregnancy |
|
| Maternal thyroid function and child educational attainment: prospective cohort study |
|
| Meal-induced inflammation: postprandial insights from the Personalised REsponses to DIetary Composition Trial (PREDICT) study in 1000 participants |
|
| Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics |
|
| Mendelian randomisation study for statin treatment – Authors' reply |
|
| Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease |
|
| Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies |
|
| Menopausal hot flashing and endothelial function in two vascular beds: findings from a cross-sectional study of postmenopausal women |
|
| Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci |
|
| Metabolic Age Based on the BBMRI-NL 1H-NMR Metabolomics Repository as Biomarker of Age-related Disease |
|
| Metabolic characterization of menopause: cross-sectional and longitudinal evidence |
|
| Metabolic effects of breaking prolonged sitting with standing or light walking in older South Asians and White Europeans: a randomized acute study |
|
| Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? |
|
| Metabolic profiling of gestational diabetes in obese women during pregnancy. |
|
| Metabolic syndrome criteria: ready for clinical prime time or work in progress? |
|
| Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence |
|
| Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study |
|
| Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts |
|
| Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase |
|
| Metformin and lactic acidosis. Metformin: framed again? |
|
| Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses |
|
| Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. |
|
| Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial |
|
| Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT |
|
| Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment |
|
| Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA Trial |
|
| Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats |
|
| Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction |
|
| Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease |
|
| Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. |
|
| Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction |
|
| Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank |
|
| More knocks to the oxidation hypothesis for vascular disease? |
|
| Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies |
|
| Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes |
|
| Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations |
|
| Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease |
|
| Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort |
|
| multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy |
|
| Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K. |
|
| N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. |
|
